NEUROCOGNITIVE DISORDERS
Clinical trials for NEUROCOGNITIVE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new NEUROCOGNITIVE DISORDERS trials appear
Sign up with your email to follow new studies for NEUROCOGNITIVE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Alzheimer's drug trial aims to tame dangerous brain swelling
Disease control OngoingThis study is testing different dosing schedules for the Alzheimer's drug donanemab to find the best balance between clearing harmful brain plaques and minimizing a serious side effect called ARIA-E, which is brain swelling. It involves about 1,175 adults with early memory proble…
Matched conditions: NEUROCOGNITIVE DISORDERS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Zapping apathy: can a brain boost and games rekindle motivation in seniors?
Symptom relief OngoingThis study is testing whether a gentle, non-invasive brain stimulation technique, combined with cognitive training games on a tablet, can help reduce apathy in older adults with mild memory problems. Apathy is a lack of motivation that can significantly impact daily life. The tri…
Matched conditions: NEUROCOGNITIVE DISORDERS
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC
-
Brain games battle: can tech or traditional puzzles better help Alzheimer's patients?
Symptom relief OngoingThis study is testing whether digital brain games (on a device) or physical, hands-on puzzles and activities are better at helping older adults with mild to moderate Alzheimer's disease. It involves over 500 participants in Portugal and aims to see which type of activity best sup…
Matched conditions: NEUROCOGNITIVE DISORDERS
Phase: NA • Sponsor: Rsocialform - Geriatria, Lda • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC